Covid vaccines help AstraZeneca sales jump 50% in third quarter

Covid vaccines help AstraZeneca sales jump 50% in third quarter
AstraZeneca Covid-19 has reported strong revenue growth (Brian Lawless/PA)

AstraZeneca has revealed that revenues jumped by 50% in the latest quarter as it was buoyed by more than 1 billion dollars worth of Covid-19 vaccine sales.

The pharmaceutical company held firm on its earnings guidance for the year as it hailed “strong revenue growth and exceptional pipeline delivery”.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited